資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/32208
|
| 標題: | The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms |
| 作者: | Chang, Ping-Chin
Chen, Chi-Chung
Lu, Ying Chen
Lai, Chih-Cheng
Huang, Hui-Ling
Chuang, Yin-Ching
Tang, Hung-Jen |
| 貢獻者: | Chi Mei Med Ctr, Dept Internal Med
Chi Mei Med Ctr, Dept Med Res
Natl Chiayi Univ, Dept Food Sci
Chi Mei Med Ctr, Dept Intens Care Med
Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr
Chi Mei Med Ctr, Dept Med |
| 關鍵字: | Cefoperazone-sulbactam
Extended-spectrum beta-lactamases
Escherichia coli
Klebsiella pneumoniae
Inoculum size |
| 日期: | 2018-04 |
| 上傳時間: | 2019-11-15 15:45:14 (UTC+8) |
| 出版者: | ELSEVIER TAIWAN |
| 摘要: | Objectives: This study aims to assess the in vitro activity of cefoperazone alone and different cefoperazone-sulbactam ratios against different inoculum sizes of multidrug resistant organisms. Methods: Minimum inhibitory concentrations (MICs) of cefoperazone, cefoperazone-sulbactam at fixed ratio of 1: 1 and 2: 1 against a normal inoculum size of 5 x 10(5) CFU/ml and a high inoculum size of 5 x 10(7) CFU/ml were measured. Results: Each 33 isolates of extended-spectrum beta-lactamases (ESBL)-producing Escherichia coli, ESBL-producing Klebsiella pneumoniae, carbapenem-resistant E. coli, and carbapenem-resistant Pseudomonas aeruginosa and a total of 122 isolates of carbapenem-resistant Acinetobacter baumannii were collected. After the addition of sulbactam at a 1: 1 ratio, most MIC50 and MIC90 values decreased. Cefoperazone-sulbactam at a 1: 1 ratio had a higher susceptibility rate against ESBL-producing E. coli, carbapenem-resistant E. coli, and carbapenem-resistant A. baumannii than cefoperazone-sulbactam at a 2: 1 ratio (all P < 0.05). For ESBL-producing E. coli, the susceptibility rate of cefoperazone-sulbactam at ratios of (1: 1) and (2: 1) decreased from 97.0 to 87.9% and 90.9 to 60.6%, for normal to high inoculum, respectively. For ESBL-producing K. pneumoniae, both susceptibility rate of cefoperazone-sulbactam at ratios of (1: 1) and (2: 1) decreased from 75.8%, and 63.6% at normal inoculum to 51.5% and 42.4% at high inoculum. Conclusions: Cefoperazone-sulbactam at a 1: 1 ratio has greater in vitro activity against most multidrug resistant organisms than cefoperazone-sulbactam at a 2: 1 ratio. Such combinations were not influenced by the inoculum size of ESBL-producing E. coli and K. pneumoniae and could be a therapeutic option for treating severe infections. Copyright (C) 2017, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. |
| link: | http://dx.doi.org/10.1016/j.jmii.2017.08.026 |
| 關聯: | Journal of Microbiology Immunology and Infection, v.51, n.2, pp.207-213 |
| 顯示於類別: | [保健營養系(所) ] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| 10.1016-j.jmii.2017.08.026.pdf | | 406Kb | Adobe PDF | 329 | 檢視/開啟 | | index.html | | 0Kb | HTML | 1115 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
